Michelle Arkin is a chemical biologist/biochemist interested in developing first-in-class modulators of really challenging targets, such as protein-protein interactions, transcription factors, and aggregating proteins. Her lab works on protein-protein interaction networks in cancer and neurodegeneration, and also has a research 'colaboratory' called the Small Molecule Discovery Center where they run HTS, fragment discovery, and medicinal chemistry.